Get the Stockscreener App
5.26
0.57%
0.010
After Hours:
5.24
-0.02
-0.38%
Direxion Daily Pharmaceutical Medical Bull 3 X Shares stock is traded at $5.26, with a volume of 85,092.
It is up +0.57% in the last 24 hours and down -5.88% over the past month.
See More
Previous Close:
$5.25
Open:
$5.2
24h Volume:
85,092
Relative Volume:
0.86
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+6.67%
1M Performance:
-5.88%
6M Performance:
-40.61%
1Y Performance:
-17.63%
1-Day Range:
$5.01
$5.33
1-Week Range:
$5.01
$5.33
52-Week Range:
$3.62
$10.62
Direxion Daily Pharmaceutical Medical Bull 3 X Shares Stock (PILL) Company Profile
Name
Direxion Daily Pharmaceutical Medical Bull 3 X Shares
Sector
Industry
Phone
-
Address
-
Compare PILL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PILL
Direxion Daily Pharmaceutical Medical Bull 3 X Shares
|
5.26 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
289.93 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
589.47 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
592.30 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
228.07 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
519.13 | 124.43B | 0 | 0 | 0 | 0.00 |
Direxion Daily Pharmaceutical Medical Bull 3 X Shares Stock (PILL) Latest News
Northern Trust Corp Sells 2,976 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
These 3 Dividend Kings Could Supercharge Your Retirement Income - Barchart.com
WNS (NYSE:WNS) Sees Unusually-High Trading Volume – Still a Buy? - Defense World
Learn to Evaluate (PILL) using the Charts - news.stocktradersdaily.com
Medical Properties Trust Target of Unusually Large Options Trading (NYSE:MPW) - Defense World
Teva Pharmaceutical Industries Sees Unusually Large Options Volume (NYSE:TEVA) - Defense World
DURECT (NASDAQ:DRRX) Now Covered by Analysts at StockNews.com - Defense World
3 Value Stocks Poised To Grow Dividends And Buybacks Now - Barchart.com
5 Small-cap Biotech ETFs to Watch - Investing News Network
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing DistortionCVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
SPY Gains $2.1B as the Market Goes Green for the Year - Yahoo Finance
Long Term Trading Analysis for (PILL) - news.stocktradersdaily.com
SPY Adds $2B as Market Soars on China Tariff Cut - Yahoo Finance
5 Leveraged ETFs Soaring on U.S.-China Trade Truce - Yahoo Finance
Biopharma Stocks Rise as Trump Orders Drug Price Cuts - Genetic Engineering and Biotechnology News
Dr. Zhong Liu: Leading Cutting-Edge Research in AI Sleep Medicine and AI Cardiovascular Dynamics at Harvard Medical School - Barchart.com
ETF (Exchange Traded Fund): Rankings and news - marketscreener.com
What to know about leveraged and inverse ETFs - Britannica
Trump pitched sending U.S. troops to Mexico to fight drug cartels - Seeking Alpha
Envestnet Asset Management Inc. Sells 340 Shares of Direxion Daily Technology Bull 3X Shares (NYSEARCA:TECL) - Defense World
Direxion Daily 20 Year Plus Treasury Bull 3x Shares (NYSEARCA:TMF) Shares Gap Down – Should You Sell? - Defense World
Invesco Ltd. Has $403,000 Stock Holdings in Cryoport, Inc. (NASDAQ:CYRX) - Defense World
Direxion Daily AAPL Bull 2X Shares (NASDAQ:AAPU) Short Interest Up 98.3% in April - MarketBeat
Best Stocks Under $20 Right Now - Benzinga
Earnings Just Sent This Healthcare Stock To New Record Highs - Barchart.com
Renaissance Technologies LLC Lowers Stake in Direxion Daily 20 Year Plus Treasury Bear 3x Shares (NYSEARCA:TMV) - Defense World
Dividend Stocks To ResearchApril 26th - MarketBeat
3 Small-Cap Stocks Skating On Thin Ice - Barchart.com
$4.3 Million Waiver Exemption Granted by FDA on New Drug Application Fee for Promising Treatment Addressing Suicidal Depression and PTSD: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) - Barchart.com
MedTech Stocks' Earnings To Watch On May 1: BDX, CAH, BAX, DXCM & SYK - Barchart.com
Nasopharyngeal Carcinoma Treatment Market 2032: Clinical Trials, Medication, Prevalence, Statistics, Revenue, Therapies, EMA, PDMA, FDA Approvals, and Companies by DelveInsight - Barchart.com
3 Profitable Stocks Skating On Thin Ice - Barchart.com
3 Healthcare Stocks That Concern Us - Barchart.com
3 Top Big Pharma Stocks Investing Over $100 Billion In The U.S. - Barchart.com
Zacks Investment Ideas feature highlights: The Direxion Daily Small Cap Bull 3X ETF - Yahoo Finance
3 Reasons To Sell JAZZ And 1 Stock To Buy Instead - Barchart.com
Direxion Daily Financial Bear 3X Shares ETF: For Trading, Not Holding - Seeking Alpha
ETF Math: Risk/Reward Tactics with Direxion's Ed Egilinsky - The Globe and Mail
3 Healthcare Stocks With Mounting Challenges - Barchart.com
3 S&P 500 Stocks With Impressive Fundamentals - Barchart.com
$1.2 Billion Pulled From Top Gold ETF as Markets Rally - Yahoo Finance
3 Reasons To Sell GH And 1 Stock To Buy Instead - Barchart.com
(PILL) Proactive Strategies - news.stocktradersdaily.com
TNA: Buy For Big Gains On Small Caps (NYSEARCA:TNA) - Seeking Alpha
Best Stocks Under $50 Right Now - Benzinga
JPMorgan Chase & Co. Sells 119,024 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World
Zacks Industry Outlook Dr. Reddy's, Sandoz And Teva Pharmaceuticals - Barchart.com
CVS Health Vs. UnitedHealth: Which Healthcare Stock Has More Upside? - Barchart.com
Direxion Daily Financial Bull 3XNot For Building Long-Term Investment Portfolios - Seeking Alpha
Direxion Daily FTSE China Bull 3X Shares ETFTo Trade, Not Buy (NYSEARCA:YINN) - Seeking Alpha
StockWatch: Trump Tariffs Take Biopharma on a Roller Coaster Ride - Genetic Engineering and Biotechnology News
Direxion Daily Pharmaceutical Medical Bull 3 X Shares Stock (PILL) Financials Data
There is no financial data for Direxion Daily Pharmaceutical Medical Bull 3 X Shares (PILL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.23%
0.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):